Title

Chloroplast-derived anthrax and other vaccine antigens: their immunogenic and immunoprotective properties

Authors

Authors

S. Kamarajugadda;H. Daniell

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

Expert Rev. Vaccines

Keywords

anthrax vaccine; chloroplast genetic engineering; genetically modified; crops; immunization; mucosal immunity; oral delivery; protective; antigens; systemic immunity; vaccines; HEAT-LABILE ENTEROTOXIN; HIGH-YIELD EXPRESSION; VP7 FUSION PROTEIN; LACTUCA-SATIVA L.; B-SUBUNIT; TRANSGENIC POTATO; TOBACCO CHLOROPLASTS; PROTECTIVE ANTIGEN; CANINE PARVOVIRUS; NEUTRALIZING ANTIBODIES; Immunology

Abstract

Transgenic plants offer many advantages, including low cost of production (by elimination of fermenters), storage and transportation, heat stability, absence of human pathogens, protection of antigens in the stomach through bioencapsulation (when delivered orally), elimination of the need for expensive purification and sterile injections and generation of both systemic and mucosal immunity. Recent studies have demonstrated that chloroplast-derived anthrax-protective antigen elicits effective immune responses, develops neutralizing antibodies, confers complete protection against anthrax lethal toxin challenge and produces 360 million doses of vaccine in one acre of transgenic plants. Chloroplast-derived vaccine antigens are efficacious against bacterial, fungal, viral and protozoan pathogens.

Journal Title

Expert Review of Vaccines

Volume

5

Issue/Number

6

Publication Date

1-1-2006

Document Type

Review

Language

English

First Page

839

Last Page

849

WOS Identifier

WOS:000243483000017

ISSN

1476-0584

Share

COinS